Insecticid.India

  • Market Cap: Small Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE070I01018
  • NSEID: INSECTICID
  • BSEID: 532851
INR
704.75
-0.05 (-0.01%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 7.94 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

7.94 k (-53.73%) Volume

Shareholding (Mar 2026)

FII

4.50%

Held by 43 FIIs

DII

9.27%

Held by 9 DIIs

Promoter

72.30%

How big is Insecticid.India?

11-Jun-2026

As of 10th June, Insecticides India Ltd has a market capitalization of 2,096.00 Cr and reported net sales of 2,140.01 Cr and net profit of 139.42 Cr over the latest four quarters.

As of 10th June, <BR><BR>Market Cap: Insecticides India Ltd has a market capitalization of 2,096.00 Cr and is classified as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 2,140.01 Cr, while the sum of Net Profit for the same period is 139.42 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds stand at 1,084.59 Cr, and Total Assets are valued at 1,898.15 Cr.

View full answer

Who are in the management team of Insecticid.India?

11-Jun-2026

The management team of Insecticid.India includes Chairman Hari Chand Aggarwal, Managing Director Rajesh Aggarwal, and several Whole-time and Independent Directors, along with Company Secretary Sandeep Kumar, collectively providing strategic direction and governance.

The management team of Insecticid.India includes the following individuals:<BR><BR>1. **Hari Chand Aggarwal** - Chairman & Wholetime Director<BR>2. **Rajesh Aggarwal** - Managing Director<BR>3. **Nikunj Aggarwal** - Whole-time Director<BR>4. **Anil Kurnar Goyal** - Whole-time Director<BR>5. **NAVIN SHAH** - Independent Director<BR>6. **Virjesh Kumar Gupta** - Independent Director<BR>7. **Jayaraman Swaminathan** - Independent Director<BR>8. **Parveen Gupta** - Independent Director<BR>9. **Anil Kumar Bhatia** - Independent Director<BR>10. **Sandeep Kumar** - Company Secretary & Compliance Officer<BR><BR>This team brings a diverse range of expertise to the company, contributing to its strategic direction and governance.

View full answer

Why is Insecticides India Ltd falling/rising?

10-Jun-2026

As of 10-Jun, Insecticides India Ltd's stock price is at 704.80, down 3.02%, with a year-to-date decline of 1.32% and a significant 17.21% drop over the past year. The stock shows short-term weakness and reduced investor interest, alongside poor long-term growth metrics.

As of 10-Jun, Insecticides India Ltd's stock price is falling, currently at 704.80, which reflects a decrease of 21.95 or 3.02%. This decline is evident in the stock's performance today, where it underperformed its sector by 1.71%. The stock reached an intraday low of Rs 702.6, marking a drop of 3.32%. <BR><BR>Over the past week, the stock has decreased by 2.90%, while it has also shown a negative return of 2.31% over the past month. Year-to-date, the stock has fallen by 1.32%, and over the last year, it has experienced a significant decline of 17.21, which is notably worse than the broader market's decline of 10.21%. <BR><BR>Investor participation has also decreased, with delivery volume dropping by 23.23% compared to the five-day average, indicating reduced interest from investors. Although the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages, suggesting short-term weakness.<BR><BR>Additionally, the company has shown poor long-term growth, with net sales and operating profit growing at annual rates of only 8.55% and 8.73%, respectively, over the last five years. The stock's performance has been further impacted by negative results reported in December 2025 and a general underperformance compared to the market over the last year. These factors contribute to the stock's current downward trend.

View full answer

What does Insecticid.India do?

10-Jun-2026

Insecticides India Ltd is a small-cap company in the pesticides and agrochemicals sector, producing insecticides and related products. As of March 2026, it reported net sales of ₹426 Cr and a net profit of ₹12 Cr, with a market cap of ₹2,096 Cr.

Overview: <BR>Insecticides India Ltd is a small-cap company operating in the pesticides and agrochemicals industry, focusing on the production of insecticides and related products.<BR><BR>History: <BR>Insecticides India Ltd was originally incorporated as 'Insecticides (India) Private Limited' in 1996 and later converted into a Public Limited Company. The company did not engage in any business from December 1996 until October 2001, with commercial production commencing in March 2002. The latest reported financial results are for the quarter ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 426 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 12 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 2,096 Cr (Small Cap) <BR><BR>Key Metrics: <BR>P/E: 15.00 <BR>Industry P/E: 29 <BR>Dividend Yield: 0.28% <BR>Debt-Equity: 0.18 <BR>Return on Equity: 12.34% <BR>Price to Book: 1.75 <BR><BR>Contact Details: <BR>Address: 401-402 Lusa Tower, Azadpur Commercial Complex Delhi Delhi : 110033 <BR>Phone: 91-11-27671990-04 <BR>Email: investor@insecticidesindia.com <BR>Website: http://www.insecticidesindia.com

View full answer

Should I buy, sell or hold Insecticides India Ltd?

30-May-2026

Are Insecticides India Ltd latest results good or bad?

29-May-2026

Insecticides India Ltd's latest results show strong revenue growth of 18.76% year-on-year, reaching ₹426.26 crore, but net profit fell by 15.69% to ₹11.71 crore, with declining margins raising concerns about operational challenges. Investors should be cautious due to the disparity between revenue growth and profitability.

The latest results for Insecticides India Ltd present a mixed picture. On one hand, the company achieved a significant revenue growth of 18.76% year-on-year, reaching ₹426.26 crore in Q4 FY26. This indicates strong top-line performance and suggests that demand for its products remains robust.<BR><BR>However, the profitability metrics are concerning. The net profit for the quarter fell by 15.69% year-on-year to ₹11.71 crore, marking a significant decline. Additionally, the operating margin dropped to 6.01%, the lowest in eight quarters, which raises questions about cost management and pricing power in a competitive market. The profit after tax margin also decreased to 2.75%, down from 3.87% in the same quarter last year.<BR><BR>Overall, while the revenue growth is a positive sign, the decline in net profit and margins indicates operational challenges that could affect the company's financial health moving forward. Investors may need to be cautious, as the divergence between revenue growth and profitability suggests underlying issues that need to be addressed.

View full answer

Has Insecticides India Ltd declared dividend?

01-Feb-2026

Yes, Insecticides India Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of February 6, 2026. While recent total returns have been negative, longer-term performance shows significant growth, particularly a 93.57% total return over the past five years.

Insecticides India Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2<BR>- Ex-date: 06 Feb 26<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -16.61%, the dividend return was 0.28%, resulting in a total return of -16.33%.<BR><BR>In the 6-month period, the price return was -43.79%, the dividend return was 0.19%, leading to a total return of -43.6%.<BR><BR>Over the 1-year period, the price return was -4.29%, the dividend return was 0.32%, which resulted in a total return of -3.97%.<BR><BR>In the 2-year period, the price return was -6.92%, the dividend return was 0.71%, culminating in a total return of -6.21%.<BR><BR>During the 3-year period, the price return was 4.63%, the dividend return was 1.75%, resulting in a total return of 6.38%.<BR><BR>In the 4-year period, the price return was 28.32%, the dividend return was 3.10%, leading to a total return of 31.42%.<BR><BR>For the 5-year period, the price return was 89.25%, the dividend return was 4.32%, resulting in a total return of 93.57%.<BR><BR>Overall, while Insecticides India Ltd has declared a dividend, the total returns over the shorter periods have been negative, indicating a challenging performance in the recent past. However, the longer-term returns show significant growth, particularly over the 5-year period.

View full answer

Is Insecticid.India technically bullish or bearish?

03-Dec-2025

As of December 2, 2025, the market trend has shifted to a bearish stance with moderate strength, indicated by bearish MACD, Bollinger Bands, moving averages, and KST on various time frames, alongside a lack of trend signals in Dow Theory and OBV.

As of 2 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST is also bearish on the weekly chart, contributing to the overall bearish sentiment. The lack of trend signals in the Dow Theory and OBV further supports the bearish outlook.

View full answer

Is Insecticid.India overvalued or undervalued?

14-Nov-2025

As of November 13, 2025, Insecticid.India's valuation has shifted from very attractive to attractive, indicating it is undervalued with a PE ratio of 13.04, an EV to EBITDA of 9.20, and a PEG ratio of 0.85, especially when compared to peers like UPL and P I Industries, despite a recent 1-year return of -12.71% against the Sensex's 8.74%.

As of 13 November 2025, the valuation grade for Insecticid.India has moved from very attractive to attractive. Based on the analysis, the company appears to be undervalued. The key ratios indicate a PE ratio of 13.04, an EV to EBITDA of 9.20, and a PEG ratio of 0.85, all of which suggest a favorable valuation compared to its peers.<BR><BR>Insecticid.India's valuation can be compared to UPL, which has a PE ratio of 26.8, and P I Industries, which is considered very expensive with a PE of 35.84. These comparisons highlight that Insecticid.India is trading at a significantly lower valuation relative to its peers in the pesticides and agrochemicals industry. Despite recent underperformance against the Sensex, with a 1-year return of -12.71% compared to the Sensex's 8.74%, the company's fundamentals suggest it is positioned for potential growth.

View full answer

How has been the historical performance of Insecticid.India?

13-Nov-2025

Insecticid.India has shown steady growth in net sales and profitability, with net sales increasing from 1,193.51 Cr in Mar'19 to 1,999.95 Cr in Mar'25, and profit after tax rising from 62.98 Cr to 141.45 Cr in the same period, despite rising operational costs. Total assets also grew to 1,898.15 Cr in Mar'25, indicating a positive overall financial trajectory.

Answer:<BR>The historical performance of Insecticid.India shows a steady growth in net sales and profitability over the years, with significant fluctuations in certain metrics.<BR><BR>Breakdown:<BR>Insecticid.India's net sales have increased from 1,193.51 Cr in Mar'19 to 1,999.95 Cr in Mar'25, reflecting a consistent upward trend. Total operating income followed a similar trajectory, reaching 1,999.95 Cr in Mar'25 from 1,801.33 Cr in Mar'23. However, total expenditure saw a rise to 1,778.74 Cr in Mar'25 from 1,679.44 Cr in Mar'23, indicating increased operational costs. The operating profit (PBDIT) has shown improvement, rising to 228.21 Cr in Mar'25 from 123.15 Cr in Mar'23, while profit before tax also increased to 192.20 Cr in Mar'25 from 83.60 Cr in Mar'23. Consequently, profit after tax reached 141.45 Cr in Mar'25, up from 62.98 Cr in Mar'23. The company's total assets grew to 1,898.15 Cr in Mar'25 from 1,696.31 Cr in Mar'23, while total liabilities increased to 1,898.15 Cr in Mar'25 from 1,719.22 Cr in Mar'24. Cash flow from operating activities improved significantly, resulting in a net cash inflow of 42.00 Cr in Mar'24, compared to a net outflow of 17.00 Cr in Mar'23. Overall, Insecticid.India has demonstrated a positive growth trajectory in sales and profits, despite some fluctuations in expenses and liabilities.

View full answer

Who are the top shareholders of the Insecticid.India?

17-Jul-2025

The top shareholders of Insecticid.India include Rajesh Kumar Aggarwal with 16.63%, HDFC Small Cap Fund at 9.07%, and individual investors holding 10.43%. Foreign Institutional Investors collectively own 4.49%, with no pledged promoter holdings reported.

The top shareholders of Insecticid.India include the promoters, with Rajesh Kumar Aggarwal holding the highest individual stake at 16.63%. Additionally, mutual funds have a significant presence, with HDFC Small Cap Fund being the highest public shareholder at 9.07%. Foreign Institutional Investors (FIIs) collectively hold 4.49% through 45 different entities. Individual investors also have a notable share, accounting for 10.43% of the holdings. There are no pledged promoter holdings reported.

View full answer

When is the next results date for Insecticid.India?

06-Jun-2025

No Upcoming Board Meetings

What is the bonus history of the Insecticid.India?

06-Jun-2025

Insecticides India Ltd has a history of issuing bonus shares, with the most recent being a 1:2 bonus announced on September 30, 2022, and a previous 1:2 bonus issued on April 17, 2015. This reflects the company's commitment to rewarding its shareholders.

Insecticides India Ltd has a history of bonus issues. The most recent bonus was a 1:2 issue, which was announced with an ex-date of September 30, 2022, and the record date was October 3, 2022. Prior to that, the company also issued a bonus in a 1:2 ratio on April 17, 2015, with an ex-date of April 16, 2015. This indicates that the company has consistently rewarded its shareholders with bonus shares in the past.

View full answer

Who are the peers of the Insecticid.India?

03-Jun-2025

Peers of Insecticid.India include P I Industries, UPL, Bayer CropSci., and others. Insecticid.India has average management risk, below average growth, and the highest 1-year return at 65.72%.

Peers: The peers of Insecticid.India are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, India Pesticides, Meghmani Organi., Punjab Chemicals, Astec Lifescienc, and Heranba Inds.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and P I Industries, while Good management risk is found at Sumitomo Chemi. Average management risk is present at Insecticid.India, UPL, India Pesticides, Punjab Chemicals, and Heranba Inds. Below Average management risk is noted at Meghmani Organi. and Astec Lifescienc. For growth, Excellent growth is seen only at P I Industries, while Below Average growth is found at Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Insecticid.India, UPL, India Pesticides, Punjab Chemicals, and Heranba Inds, with Meghmani Organi. showing Below Average growth as well. Excellent capital structure is noted at P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Insecticid.India, India Pesticides, and Punjab Chemicals, while Average capital structure is observed at Meghmani Organi. and Astec Lifescienc, and Below Average at UPL and Heranba Inds.<BR><BR>Return Snapshot: Insecticid.India has the highest 1-year return at 65.72%, while Astec Lifescienc has the lowest at -35.47%. Insecticid.India's return significantly outperforms Astec Lifescienc. Additionally, UPL, Meghmani Organi., Astec Lifescienc, and Heranba Inds have negative six-month returns.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 8.55% and Operating profit at 8.73% over the last 5 years

 
2

Negative results in Mar 26

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 2,066 Cr (Small Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

28

stock-summary
Dividend Yield

0.28%

stock-summary
Debt Equity

0.18

stock-summary
Return on Equity

12.34%

stock-summary
Price to Book

1.70

Revenue and Profits:
Net Sales:
426 Cr
(Quarterly Results - Mar 2026)
Net Profit:
12 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.28%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22.02%
0%
22.02%
6 Months
0.43%
0.29%
0.72%
1 Year
-18.62%
0.22%
-18.4%
2 Years
15.92%
0.56%
16.48%
3 Years
54.53%
1.57%
56.1%
4 Years
31.96%
2.20%
34.16%
5 Years
68.62%
2.71%
71.33%

Latest dividend: 2 per share ex-dividend date: Feb-06-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05-Jun-2026 | Source : BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

03-Jun-2026 | Source : BSE

Transcript of the Earning Conference Call for the Quarter and Financial Year ended March 31 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Jun-2026 | Source : BSE

Newspaper advertisement on Notice of transfer of equity shares of the Company to IEPF

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Insecticides India Ltd has declared 20% dividend, ex-date: 06 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Insecticides India Ltd has announced 1:2 bonus issue, ex-date: 30 Sep 22

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
8.55%
EBIT Growth (5y)
8.73%
EBIT to Interest (avg)
16.05
Debt to EBITDA (avg)
0.90
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
1.58
Tax Ratio
25.32%
Dividend Payout Ratio
4.10%
Pledged Shares
0
Institutional Holding
13.77%
ROCE (avg)
13.36%
ROE (avg)
10.95%

Valuation key factors

Factor
Value
P/E Ratio
15
Industry P/E
28
Price to Book Value
1.71
EV to EBIT
11.81
EV to EBITDA
9.97
EV to Capital Employed
1.60
EV to Sales
1.06
PEG Ratio
NA
Dividend Yield
0.28%
ROCE (Latest)
14.28%
ROE (Latest)
12.34%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (8.93%)

FIIs

Held by 43 FIIs (4.5%)

Promoter with highest holding

Rajesh Kumar Aggarwal (16.63%)

Highest Public shareholder

Hdfc Small Cap Fund (9.06%)

Individual Investors Holdings

11.03%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 18.76% vs 31.71% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -15.69% vs 78.99% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "426.26",
          "val2": "358.92",
          "chgp": "18.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.60",
          "val2": "28.47",
          "chgp": "-10.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.32",
          "val2": "2.14",
          "chgp": "101.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.71",
          "val2": "13.89",
          "chgp": "-15.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.01%",
          "val2": "7.93%",
          "chgp": "-1.92%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 3.51% vs -3.90% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 6.06% vs 34.29% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,328.83",
          "val2": "1,283.78",
          "chgp": "3.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "174.06",
          "val2": "161.07",
          "chgp": "8.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.88",
          "val2": "3.32",
          "chgp": "137.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "117.21",
          "val2": "110.51",
          "chgp": "6.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.10%",
          "val2": "12.55%",
          "chgp": "0.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 4.40% vs -3.09% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -0.14% vs 35.18% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,713.75",
          "val2": "1,641.48",
          "chgp": "4.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "201.45",
          "val2": "191.96",
          "chgp": "4.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.56",
          "val2": "4.73",
          "chgp": "165.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "127.70",
          "val2": "127.88",
          "chgp": "-0.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.75%",
          "val2": "11.69%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 7.00% vs 1.71% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -1.84% vs 38.73% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,140.01",
          "val2": "1,999.95",
          "chgp": "7.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "227.05",
          "val2": "221.21",
          "chgp": "2.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.88",
          "val2": "6.86",
          "chgp": "146.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "139.41",
          "val2": "142.02",
          "chgp": "-1.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.61%",
          "val2": "11.06%",
          "chgp": "-0.45%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
426.26
358.92
18.76%
Operating Profit (PBDIT) excl Other Income
25.60
28.47
-10.08%
Interest
4.32
2.14
101.87%
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.71
13.89
-15.69%
Operating Profit Margin (Excl OI)
6.01%
7.93%
-1.92%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 18.76% vs 31.71% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -15.69% vs 78.99% in Mar 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
1,328.83
1,283.78
3.51%
Operating Profit (PBDIT) excl Other Income
174.06
161.07
8.06%
Interest
7.88
3.32
137.35%
Exceptional Items
0.00
0.00
Consolidate Net Profit
117.21
110.51
6.06%
Operating Profit Margin (Excl OI)
13.10%
12.55%
0.55%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 3.51% vs -3.90% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 6.06% vs 34.29% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,713.75
1,641.48
4.40%
Operating Profit (PBDIT) excl Other Income
201.45
191.96
4.94%
Interest
12.56
4.73
165.54%
Exceptional Items
0.00
0.00
Consolidate Net Profit
127.70
127.88
-0.14%
Operating Profit Margin (Excl OI)
11.75%
11.69%
0.06%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 4.40% vs -3.09% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -0.14% vs 35.18% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
2,140.01
1,999.95
7.00%
Operating Profit (PBDIT) excl Other Income
227.05
221.21
2.64%
Interest
16.88
6.86
146.06%
Exceptional Items
0.00
0.00
Consolidate Net Profit
139.41
142.02
-1.84%
Operating Profit Margin (Excl OI)
10.61%
11.06%
-0.45%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 7.00% vs 1.71% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -1.84% vs 38.73% in Mar 2025

stock-summaryCompany CV
About Insecticides India Ltd stock-summary
stock-summary
Insecticides India Ltd
Small Cap
Pesticides & Agrochemicals
Insecticides India Limited (IIL) was originally incorporated as 'Insecticides (India) Private Limited' on 18th December 1996. Subsequently, the Company was converted into Public Limited Company. The Company was not carrying out any business from December 1996 till October 2001. The commercial production started in March, 2002 at Chopanki Unit in Rajasthan with an installed capacity of 29.40 Lacs litres of EC, and 2400 MTs of Granules.
Company Coordinates stock-summary
Company Details
401-402 Lusa Tower, Azadpur Commercial Complex Delhi Delhi : 110033
stock-summary
Tel: 91-11-27671990-04
stock-summary
investor@insecticidesindia.com
Registrar Details
Alankit Assignments Ltd , Alankit House , 2 E/21, Jhandewala Extension, New Delhi